ClinicalTrials.gg
RecruitingNCT07477184Updated Mar 17, 2026

Sleep Well Firefighters: An App-based Program to Improve Sleep, Cognition, and Behavioral Health in Firefighters

An interventional study of Sleep enhancement intervention and Standard of Care (Investigator Choice) in Sleep Health, Stress and Anxiety, sponsored by California Polytechnic State University-San Luis Obispo. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-17.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by California Polytechnic State University-San Luis Obispo · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this pilot study is to examine the feasibility and acceptability of an app-based sleep program designed to help firefighters improve their sleep.

Read the detailed description

The purpose of this pilot study is to examine the feasibility and acceptability of an app-based sleep program designed to help firefighters improve their sleep. This trial will recruit firefighters working on the Central Coast of California. Upon completing screening procedures and an informed consent, participants will be asked to complete questionnaires related to sleep, behavioral health, and cognition and sleep patterns will be objectively assessed using research grade wrist-worn accelerometers. Participants will then be randomized to receive the Sleep Well intervention (mobile iOS app + monthly phone coaching; N=25) or a control condition (handout on sleep in firefighters; N=25). Over a three month study period, participants randomized to the Sleep Well intervention will be asked to 1) track their sleep, physical activity, eating, and stress; 2) complete weekly, in-app learning modules informed by social cognitive theory and cognitive behavioral therapy for insomnia covering topics such as sleep hygiene, bedtime routines, healthy eating and activity patterns, and managing stress; and 3) participate in three monthly coaching phone calls with a trained study interventionist. After the three month study period, all participants will be asked to repeat baseline assessments. Those in the Sleep Well intervention group will also be asked for user feedback. Quantitative data will inform feasibility of digitally delivered, behavioral sleep programming designed for firefighters. Findings will inform intervention strategies targeting healthy sleep behaviors to improve health and cognition in firefighters and guide the study protocol for a full-scale trial

02

Conditions studied

  • Sleep Health
  • Stress
  • Anxiety
  • Physical Activity
  • Nutrition
  • Cognition

Browse trials for

Keywords

  • Firefighters
  • Behavioral Sleep Health
  • Digital Health
  • Cognition
03

In context

Anxiety Disorders Unverified

7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.

This study's planned enrollment of 50 is below the median of 80 across 6,103 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

California Polytechnic State University-San Luis Obispo is the lead sponsor of 29 studies on the registry; 7 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Current CalFire Wildfire firefighter in Central Coast region or City of San Luis Obispo Firefighter (non-volunteer and not a primarily administrator status)
  • English Speaking
  • Have an iPhone /iPad
  • Age >= 18
  • Self-reported interest in improving sleep functioning.

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Sleep Education Control Group

    The Sleep Education Control Arm will be provided basic Sleep Education materials that are Standard of Care and available to all Firefighters.

    Behavioral: Standard of Care (Investigator Choice)

  • Experimental
    Sleep Well Intervention Group

    The Sleep Well Intervention Group will receive access to a digital Sleep Health App designed for Firefighters and will be asked to participate in monthly coaching phone calls aimed at improving their sleep health.

    Behavioral: Sleep enhancement intervention

Interventions

  • BehavioralSleep enhancement intervention

    The Sleep Well Intervention Group will receive access to a digital Sleep Health App designed for Firefighters and will be asked to participate in monthly coaching phone calls aimed at improving their sleep health.

  • BehavioralStandard of Care (Investigator Choice)

    Basic Sleep Education materials that are Standard of Care and available to all Firefighters will be administered.

06

What researchers measure

Primary outcomes

  1. Recruitment capability

    Recruitment capability: Number of participants enrolled per month (target of 5 enrolled per month)

    Time frame: From Baseline through Study Completion (12 weeks).

  2. Intervention Fidelity

    Fidelity: The extent to which an intervention is delivered as intended (target: \>80% fidelity score).

    Time frame: From Baseline through Study Completion (12 weeks).

  3. Intervention Adherence

    Change in sleep behaviors assessed via in-app tracking (i.e., self-report of sleep behaviors over the study intervention period).

    Time frame: From Baseline (week 0) through Study Completion (12 weeks).

  4. Acceptability

    Participants will be asked to rate the usefulness and satisfaction with app and phone-sessions, using a questionnaire that includes rating scales of various aspects of the program.

    Time frame: At Study Completion (12 weeks).

  5. Retention

    Retention: Number of participants who remained in the study throughout the project period of the total number of participants recruited at baseline (Target of 80% retention rate; Reasons for dropout will be collected);

    Time frame: At Baseline (week 0) through Study Completion (week 12).

  6. Assessment procedures

    Assessment procedures: The extent to which study assessments can be administered as planned; assessment procedures are acceptable to participants; and data collection is complete.

    Time frame: At baseline (week 0) through Study Completion (week 12).

  7. Adherence

    Logins on the mobile Sleep Well App (Goal: \>75% of expected logins on the mobile Sleep Well app)

    Time frame: At baseline (week 0) through Study completion (week 12).

Secondary outcomes

  1. Sleep, movement, and light exposure

    Sleep, circadian rhythm, movement, temperature, and exposure to light will be objectively measuring using the wrist-worn Gene Active

    Time frame: 7 days upon enrollment (Baseline; week 0) and 7 days prior to the end of the intervention (week 12).

  2. BMI

    Body mass index (BMI) will be calculated as weight in kilograms divided by height in meters squared (kg/m²). Weight will be measured using a calibrated digital scale and height using a stadiometer. Self-reported values may be used if direct measurement is not available.

    Time frame: At Baseline (week 0) and at Study Completion (week 12).

  3. Depressive symptoms

    Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9), a 9-item self-report measure of depression severity. Each item is scored from 0 to 3, yielding a total score ranging from 0 to 27, with higher scores indicating greater depressive symptom severity.

    Time frame: At Baseline (week 0) and at Study Completion (week 12).

  4. Caffeine

    A beverage questionnaire will be administered. Daily caffeine intake will be calculated as average milligrams of caffeine consumed per day.

    Time frame: At Baseline (week 0) and at Study Completion (week 12).

  5. Anxiety

    Anxiety levels will be assessed using the Beck Anxiety Inventory. The Beck Anxiety Inventory (BAI) is a 21-item self-report measure assessing anxiety symptoms. Total scores range from 0 to 63, with higher scores indicating greater anxiety severity.

    Time frame: At Baseline (week 0) and at Study Completion (week 12).

  6. Stress

    Stress will be measured using the Perceived Stress Scale. The Perceived Stress Scale-10 (PSS-10) is a 10-item self-report measure assessing perceived stress over the past month. Total scores range from 0 to 40, with higher scores indicating greater perceived stress.

    Time frame: At Baseline (week 0) and at Study Completion (week 12).

  7. Quality of Life

    Quality of life will be measured using Short Form Health Survey - SF-12. Scores range from 0 to 100, with higher scores indicating better mental health status.

    Time frame: At Baseline (week 0) and at Study Completion (week 12).

  8. Psychomotor Vigilance

    Attention will be measured using a psychomotor vigilance task that collects reaction time. The primary metric will be mean reaction time in milliseconds (ms), with higher values indicating slower responses and reduced vigilance.

    Time frame: At Baseline (week 0) and at Study Completion (week 12).

  9. Sleep Diary

    Participants will be asked to complete a log reporting the time they got into bed and got out of bed.

    Time frame: 7 days upon enrollment (Baseline; week 0) and 7 days prior to the end of the intervention (week 12).

  10. Epworth Sleepiness Scale (ESS) Score

    The Epworth Sleepiness Scale (ESS) is an 8-item self-report questionnaire assessing daytime sleepiness. Total scores range from 0 to 24, with higher scores indicating greater daytime sleepiness.

    Time frame: Baseline (Week 0) to Post-Intervention (Week 12)

  11. Pittsburgh Sleep Quality Index (PSQI) Global Score

    The Pittsburgh Sleep Quality Index (PSQI) is a 19-item self-report measure assessing sleep quality. The global score ranges from 0 to 21, with higher scores indicating poorer sleep quality.

    Time frame: Baseline (Week 0) to Post-Intervention (Week 12)

07

Study locations

1 of 1 sites recruiting
  • California Polytechnic University - San Luis Obispo
    San Luis Obispo, California 93401, United States
    Recruiting
    • Selene Tobin, PhD · Contactsytobin@calpoly.edu · 805-756-5653
    • Noemi Alarcon, MS · Contactnoalarco@calpoly.edu · 805-756-5694
    • Selene Tobin, PhD · Principal investigator
    • Suzanne Phelan, PhD · Principal investigator
    • Sarah Keadle, PhD · Sub investigator
    • Kelly Bennion, PhD · Sub investigator
    • James Antony, PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — De-identified individual participant data will not be made publicly available. Aggregate results will be reported in peer-reviewed publications and scientific presentations.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Sep 2026, 8 months after the start.

Of 3,871 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 8 months is below that.

Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2026
First posted
Mar 17, 2026
StartActual
Jan 5, 2026
Primary completionEst.
Sep 2026
CompletionEst.
Sep 2026
Last update
Mar 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07477184
Lead sponsor
California Polytechnic State University-San Luis Obispo
Responsible party
Selene Tobin (Assistant Professor, California Polytechnic State University-San Luis Obispo) — Principal investigator
First posted
Mar 17, 2026
Start date
Jan 5, 2026
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Mar 17, 2026

Study contacts

Selene Y Tobin, PhD
Contact
sytobin@calpoly.edu
805-756-5653
Noemi Alacron, MS
Contact
noalarco@calpoly.edu
805-756-5694
Suzanne Phelan, PhD
principal investigator · Cal Poly
Selene Tobin, PhD
principal investigator · Cal Poly

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion